Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport.
about
Connecting the dots between tau dysfunction and neurodegenerationDisruption of axonal transport perturbs bone morphogenetic protein (BMP)--signaling and contributes to synaptic abnormalities in two neurodegenerative diseasesNebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signalingQuantitative analysis of APP axonal transport in neurons: role of JIP1 in enhanced APP anterograde transportRoles of tau protein in health and disease.Epigenetic induction of EGR-1 expression by the amyloid precursor protein during exposure to novelty.Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.Tau protein modifications and interactions: their role in function and dysfunction.The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques.Elevated copper ion levels as potential cause of impaired kinesin-dependent transport processes.Hypoxia-up-regulated mitochondrial movement regulator does not contribute to the APP/PS1 double transgenic mouse model of Alzheimer's disease.Axonal transport proteins as biomarkers of neurodegeneration?Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease.Using the QAPgrid Visualization Approach for Biomarker Identification of Cell-Specific Transcriptomic Signatures.
P2860
Q26996848-984D9E33-2722-4382-9A24-565DA44F0F28Q27315692-CD57C4AF-09E6-4ABD-9696-91DC187070C0Q27320509-E393E2E7-9FF8-44E4-876A-46BAB33AEB72Q30597672-76796F18-476A-45AA-9486-924ED2D8AB20Q33559303-AF2307C4-AE7B-4FC8-A836-675412A1EDCEQ34997321-3EA06BCD-396A-43EA-87D3-70625245C705Q37290158-2B34CFBA-A65D-48F9-B2DC-07DDAA125F91Q37684106-67E5F5D7-DFE0-4EFA-853F-C3C6B6B7DB40Q39755143-F0B4ADBE-3019-4D51-A82F-32A646056999Q42705554-D6A710C7-3150-402A-BDF9-8C3A2CA55B02Q44811339-3016B9AC-914D-4BB8-9868-DF28529AC51FQ47996935-6A665263-A39C-43CF-81CA-DC2BB1DE8B49Q48663169-DA18172E-59DB-4379-8AB5-892416738313Q50541983-E927D263-4386-41A8-AEFC-361E3F1A40A4
P2860
Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Levels of kinesin light chain ...... ions for axoplasmic transport.
@en
Levels of kinesin light chain ...... ions for axoplasmic transport.
@nl
type
label
Levels of kinesin light chain ...... ions for axoplasmic transport.
@en
Levels of kinesin light chain ...... ions for axoplasmic transport.
@nl
prefLabel
Levels of kinesin light chain ...... ions for axoplasmic transport.
@en
Levels of kinesin light chain ...... ions for axoplasmic transport.
@nl
P2093
P2860
P1476
Levels of kinesin light chain ...... tions for axoplasmic transport
@en
P2093
Charles Nicaise
Marina Morel
Valérie Suain
P2860
P2888
P356
10.1007/S00401-011-0901-4
P577
2011-11-18T00:00:00Z